维普期刊资源整合服务平台（V6.5）

102篇 您的检索式：作者名="AmLer"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with Erlotinib 显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin Oncol2005，23，：	1
2	HER pathway gene expression analysis in a phase II study of pertuzumab+gemcitabine vs gemcitabine+placebo in patients with platinum-resistant epithelial ovarian cancer显示文摘	Amler L Makhija S Januario T		0，，：	1
3	Genomic instability in lp and human malignancies显示文摘	Schwab M Praml C Amler LC	1996	Genes Chromosomes Cancer1996，16，4：	1
4	Treatment of attention -deficit/hyperactivity disorder: Overview of the evidence 显示文摘	Brown RT Amler RW Freeman WS	2005	Pediatrics2005，115，6：	1
5	Evaluation of dif- ferent biomarkers to predict individual radiosensitivity in an in- ter-laboratory comparison-lessons for future studies显示文摘	GREVE B BI3LLING T AMLER S	2012	PLoS One2012，7，47：	1
6	Reconstruction of the anterior cruciate ligament: dynamic strain evaluation of the graft显示文摘	Milan Handl Milan Dr?ík Giuliano Cerulli Ctibor Povy?il Juraj Chlpík Ferdinand Varga Ev?en Amler Tomá? Tr?	2007	Knee Surgery Sports Traumatology Arthroscopy2007，，3：	1
7	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non small cell lung cancer treated with chemo- therapy alone and in combination with erlotinib 显示文摘	Eberhard D A Johnson B E Amler L C Goddard A D Heldens S L Herbst R S	2005	J Clin On- col2005，23，：	1
8	Mutations in the epidermal growth factor receptor and in K-ras are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin Oncol2005，23，25：	1
9	Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer,fallopian tube cancer,or primary peritoneal cancer显示文摘	Makhija S Amler LC Glenn D		0，，07：	1
10	Selective approaches to basic neurobehavioral testing of children in environmental health studies显示文摘	AMLER R W GIBERTINI M LYBARGER J A	1996	Neurotoxicol Teratol1996，18，4：	1
11	Adoption of an adult environmental neurobehavioral test battery 显示文摘	AMLER R W LYBARGER J A ANGER W K	1994	Neurotoxicol Teratol1994，416，5：	1
12	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small- cell lung cancer treated with chemotherapy alone and in combination with erlotinib 显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin Oncol2005，23，25：	1
13	Mutations in the epidermal growth factor receptor and in KRAS are pre- dictive and prognostic indicators in patients with non - small- cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin Oncol2005，23，：	1
14	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin 0ncol2005，23，25：	1
15	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard D A Johnson B E Amler L C		0，，25：	1
16	Mutations in the epidermal growth factor receptor and in KRAS are pre- dictive and prognostic indicators in patients with non- small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib 显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin Oncol2005，23，：	1
17	Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer显示文摘	Makhija S Amler LC Glenn D	2010	J Clin Oncol2010，28，7：	1
18	Mutations in the epidermal growth factor receptor and in K-RAS are predictive and prognostic indicators in patients with nonsmall cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard DA Johnson BE AmLer LC		0，，25：	1
19	Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R显示文摘	AMLER LC AGUS DB LEDUC C	2000	Cancer Res2000，60，21：	1
20	Clinical activity of gemc-itabine plus pertuzumab in platinum-resistant ovarian cancer,fal-lopian tube cancer,or primary peritoneal cancer显示文摘	Makhija S Amler LC Glenn D	2010	J Clin On-col2010，28，7：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示